Overview of Vaccines

Gordon Ada

doi:10.1385/1-59259-399-2:1

Overview of Vaccines

Gordon Ada^*

^*Corresponding author for this work

John Curtin School of Medical Research

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

9 Citations (Scopus)

Abstract

Most vaccines are designed as a prophylactic measure to stimulate a lasting immune response so that on subsequent exposure to the particular infectious agent, the extent of infection is reduced to such an extent that disease does not occur (1). There is also increasing interest in designing vaccines that may be effective as a therapeutic measure, immunotherapy.

Original language	English
Title of host publication	Vaccine Protocols
Editors	Andrew Robinson, Michael J. Hudson, Martin P. Cranage
Place of Publication	New Jersey
Publisher	Humana Press
Pages	1-17
ISBN (Electronic)	978-1-59259-399-6, 1-59259-399-2
ISBN (Print)	978-1-58829-140-0, 1-58829-140-5
DOIs	https://doi.org/10.1385/1-59259-399-2:1
Publication status	Published - 2003

Publication series

Name	Methods in Molecular Medicine
Publisher	Humana Press
Volume	87
ISSN (Print)	1543-1894
ISSN (Electronic)	1940-6037

Access to Document

10.1385/1-59259-399-2:1

Cite this

@inbook{60792c2ed13e41fc8c1a6d9c119e1af7,

title = "Overview of Vaccines",

abstract = "Most vaccines are designed as a prophylactic measure to stimulate a lasting immune response so that on subsequent exposure to the particular infectious agent, the extent of infection is reduced to such an extent that disease does not occur (1). There is also increasing interest in designing vaccines that may be effective as a therapeutic measure, immunotherapy.",

author = "Gordon Ada",

year = "2003",

doi = "10.1385/1-59259-399-2:1",

language = "English",

isbn = "978-1-58829-140-0",

series = "Methods in Molecular Medicine",

publisher = "Humana Press",

pages = "1--17",

editor = "Andrew Robinson and Hudson, {Michael J.} and Cranage, {Martin P.}",

booktitle = "Vaccine Protocols",

}

TY - CHAP

T1 - Overview of Vaccines

AU - Ada, Gordon

PY - 2003

Y1 - 2003

N2 - Most vaccines are designed as a prophylactic measure to stimulate a lasting immune response so that on subsequent exposure to the particular infectious agent, the extent of infection is reduced to such an extent that disease does not occur (1). There is also increasing interest in designing vaccines that may be effective as a therapeutic measure, immunotherapy.

AB - Most vaccines are designed as a prophylactic measure to stimulate a lasting immune response so that on subsequent exposure to the particular infectious agent, the extent of infection is reduced to such an extent that disease does not occur (1). There is also increasing interest in designing vaccines that may be effective as a therapeutic measure, immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0642372762&partnerID=8YFLogxK

U2 - 10.1385/1-59259-399-2:1

DO - 10.1385/1-59259-399-2:1

M3 - Chapter

SN - 978-1-58829-140-0

SN - 1-58829-140-5

T3 - Methods in Molecular Medicine

SP - 1

EP - 17

BT - Vaccine Protocols

A2 - Robinson, Andrew

A2 - Hudson, Michael J.

A2 - Cranage, Martin P.

PB - Humana Press

CY - New Jersey

ER -

Overview of Vaccines

Abstract

Publication series

Access to Document

Other files and links

Fingerprint

Cite this